Cite Filings / SABS / 0000950170-23-066553
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

SAB Biotherapeutics, Inc. · Filed 2023-11-29 · Acc 0000950170-23-066553

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , sabs-20231129.htm

Around this filing

  • 2024-01-03 8-K Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  • 2023-11-29 8-K Regulation FD disclosure
  • 2023-11-28 EFFECT Notice of Effectiveness
  • 2023-11-28 4 Director acquired 4,584,571 shares (option exercise)
  • 2023-11-28 4 Director acquired 4,584,571 shares (option exercise)
  • 2023-11-28 4 Director acquired 2,857,142 shares (option exercise)
  • 2023-11-22 8-K Bylaws or fiscal year change · Shareholder vote results

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading sabs-20231129.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…